We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$301M
AUM Growth
+$1.94M
Cap. Flow
-$7.95M
Cap. Flow %
-2.64%
Top 10 Hldgs %
53.38%
Holding
31
New
1
Increased
15
Reduced
13
Closed
2

Top Buys

Rank Stock Value
1
RIOT icon
Riot Platforms
RIOT
+$9.52M
2
PXD
Pioneer Natural Resource Co.
PXD
+$3.72M
3
FFIV icon
F5
FFIV
+$3.17M
4
VZ icon
Verizon
VZ
+$2.87M
5
EG icon
Everest Group
EG
+$2.37M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$13.2M
2
FSLR icon
First Solar
FSLR
+$6.27M
3
RNR icon
RenaissanceRe
RNR
+$5.28M
4
XYZ
Block Inc
XYZ
+$3.4M
5
HCAT icon
Health Catalyst
HCAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Financials 32.24%
2 Technology 26.07%
3 Healthcare 20.35%
4 Energy 14.82%
5 Real Estate 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVN icon
1
Devon Energy
DVN
$52.1B
$20.8M 6.9%
410,055
+2,923
+0.7% +$166K
RNR icon
2
RenaissanceRe
RNR
$13.3B
$18.1M 6.03%
90,540
-26,224
-22% -$5.28M
SHOP icon
3
Shopify
SHOP
$152B
$16.8M 5.59%
350,205
-15,359
-4% -$676K
AMD icon
4
Advanced Micro Devices
AMD
$776B
$16.4M 5.45%
167,278
+13,169
+9% +$1.07M
QCOM icon
5
Qualcomm
QCOM
$155B
$16.3M 5.42%
127,754
+2,787
+2% +$347K
AIG icon
6
American International
AIG
$41.7B
$15M 5.01%
298,752
-5,297
-2% -$309K
JNJ icon
7
Johnson & Johnson
JNJ
$618B
$14.7M 4.89%
94,799
+8,662
+10% +$1.4M
RIOT icon
8
Riot Platforms
RIOT
$7.63B
$14.6M 4.86%
+1,462,970
New +$9.52M
BMY icon
9
Bristol-Myers Squibb
BMY
$133B
$14.2M 4.72%
204,614
+20,492
+11% +$1.45M
V icon
10
Visa
V
$684B
$13.5M 4.5%
60,046
-2,289
-4% -$509K
MA icon
11
Mastercard
MA
$506B
$13.3M 4.42%
36,558
-835
-2% -$303K
FANG icon
12
Diamondback Energy
FANG
$57.1B
$12.8M 4.26%
94,806
+3,012
+3% +$420K
CB icon
13
Chubb
CB
$135B
$12.4M 4.13%
63,928
-7,566
-11% -$1.59M
CI icon
14
Cigna
CI
$73.8B
$12.1M 4.03%
47,412
+1,196
+3% +$348K
PXD
15
DELISTED
Pioneer Natural Resource Co.
PXD
$11M 3.66%
53,807
+17,295
+47% +$3.72M
PETQ
16
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$10.9M 3.63%
955,925
+70,728
+8% +$785K
XYZ
17
Block Inc
XYZ
$48.4B
$9.96M 3.31%
145,113
-45,413
-24% -$3.4M
FFIV icon
18
F5
FFIV
$22.9B
$9.94M 3.31%
68,258
+21,987
+48% +$3.17M
EG icon
19
Everest Group
EG
$14.5B
$9.87M 3.28%
27,566
+6,606
+32% +$2.37M
HCAT icon
20
Health Catalyst
HCAT
$154M
$9.26M 3.08%
793,579
-188,702
-19% -$2.41M
CYBR
21
DELISTED
CyberArk
CYBR
$8.64M 2.88%
58,413
-8,588
-13% -$1.2M
GIS icon
22
General Mills
GIS
$19.1B
$5.13M 1.71%
60,006
-5,283
-8% -$422K
IRM icon
23
Iron Mountain
IRM
$36.4B
$3.48M 1.16%
65,681
+423
+0.6% +$22.2K
VZ icon
24
Verizon
VZ
$195B
$3.05M 1.02%
78,451
+72,715
+1,268% +$2.87M
NHI icon
25
National Health Investors
NHI
$3.72B
$2.73M 0.91%
52,946
+1,038
+2% +$56.6K

Similar funds

Nepsis Inc's Q1 2023 Portfolio in Review

As of Q1 2023, Nepsis Inc held 31 positions worth $301M, up 0.65% from $299M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Nepsis Inc's Q1 2023 filing shows 1 new, 15 increased, 13 reduced and 2 closed positions. Its largest new stake was Riot Platforms: 1,462,970 shares worth $14.6M. The largest sale was Jazz Pharmaceuticals, an estimated $13.2M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • Nepsis Inc's largest Q1 2023 buy was Riot Platforms: 1,462,970 shares worth $14.6M.
  • Nepsis Inc added most to Pioneer Natural Resource Co. in Q1 2023, an estimated $3.72M increase.
  • Nepsis Inc's biggest Q1 2023 reduction was RenaissanceRe, cutting an estimated $5.28M.
  • Nepsis Inc fully exited Jazz Pharmaceuticals in Q1 2023, selling an estimated $13.2M.
  • Nepsis Inc's ten largest holdings make up 53% of its $301M portfolio in Q1 2023.
  • Nepsis Inc opened 1 new position and closed 2 in Q1 2023.
  • Nepsis Inc's portfolio value rose 0.65% quarter-over-quarter to $301M.

Based on Nepsis Inc's 13F filing for Q1 2023, filed 14 Apr 2023.